Home    About Us    Medic-All    Bio B2B    Hot Topic     Expo     Login | Join Now          
Bio B2BTAHO Pharmaceuticals Ltd. 〉TAH9922 ADHD Oral Solution

TAH9922 ADHD Oral Solution

TAH9922 ADHD Oral Solution

Once-daily oral liquid ADHD treatment.

Request for Collaboration
Overview
TAH9922 is an once-daily, liquid ADHD treatment option. It is a flavored, immediate release ADHD treatment option for patients ages 6 and above. Dosing can be tailored to the treatment's need.

Uniqueness:
• Better Palatability
• Improved patient compliance via non-invasive, painless and simple application
People who like this also like
  • PHN015 (Hemorrhage stroke)PHN015 (Hemorrhage stroke)
  • ORADUR-methylphenidateORADUR-methylphenidate
  • OralPAS®OralPAS®
  • FLISA (IgE/IgG test)FLISA (IgE/IgG test)
  • low-alcohol formulation (iLEF) platformlow-alcohol formulation (iLEF) platform
  • PixoTest technologyPixoTest technology
  • R&D ManagementR&D Management
  • PipelinePipeline
  • Homogeneous antibody drugs (CHO-H01, H02, H03)Homogeneous antibody drugs (CHO-H01, H02, H03)
  • CVM-1118CVM-1118